ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,433Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 113

$354K Total Retail Price of All Prescriptions

Rank: 65 out of 113

331 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 331 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 331 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 6,180 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 350 308 1 1
OMEPRAZOLE 291 244 2 5
HYDROCODONE-ACETAMINOPHEN 280 189 S3 3 7
LISINOPRIL 279 219 4 3
POTASSIUM CHLORIDE 231 221 5 12
METFORMIN HCL 197 176 6 11
PRAVASTATIN SODIUM 194 158 7 23
FUROSEMIDE 161 158 8 6
AMLODIPINE BESYLATE 155 140 9 4
FENTANYL 154 81 S2 10 43
METOPROLOL SUCCINATE 150 127 11 10
ATENOLOL 146 140 12 16
SIMVASTATIN 142 140 13 2
ZOLPIDEM TARTRATE 126 82 14 19
AZITHROMYCIN 113 100 15 65
LOSARTAN POTASSIUM 111 111 16 13
TRIAMTERENE-HCTZ 107 96 17 26
TRIAMTERENE-HYDROCHLOROTHIAZID 99 99 18 91
ALENDRONATE SODIUM 98 98 19 22
SERTRALINE HCL 98 92 19 21
ATORVASTATIN CALCIUM 93 85 21 15
METOPROLOL TARTRATE 93 83 21 14
WARFARIN SODIUM 85 85 23 8
CITALOPRAM HBR 83 56 24 17
LOVASTATIN 74 67 25 53
DIGOXIN 73 73 26 27
GLIPIZIDE XL 73 62 26 146
MORPHINE SULFATE ER 69 56 S2 28 79
GABAPENTIN 66 53 29 18
CIPROFLOXACIN HCL 57 50 30 63
PREDNISONE 56 55 31 28
CLOPIDOGREL 56 47 31 56
DONEPEZIL HCL 53 53 33 33
SYNTHROID 52 52 34 57
NEXIUM 51 39 35 47
ENALAPRIL MALEATE 50 39 36 50
ROPINIROLE HCL 50 43 36 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.